Listar GI- GRINCAR - Artigos por título
Mostrando ítems 110-129 de 226
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
(Wolters Kluwer, 2020-07)[Abstract] Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart ... -
lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction
(PLoS One, 2024-05-21)[Abstract] Ventricular fibrillation (VF) in acute myocardial infarction (AMI) is the main cause of deaths occurring in the acute phase of an ischemic event. Although it is known that genetics may play an important role in ... -
Long-Term outcomes and durability of the mitroflow aortic bioprosthesis
(Wiley, 2016-03-14)[Abstract] Background. This study aims to determine the incidence and causes of structural valve deterioration (SVD) among all models of Mitroflow bioprostheses (A12/LX/DL), as well as to define their long-term clinical ... -
Long-term results of heart transplant in recipients older and younger than 65 years: a comparative study of mortality, rejections, and neoplasia in a cohort of 445 patients
(Elsevier, 2005-12-28)[Resumen] Background. Whether being older than 65 years should be considered an absolute counterindication to heart transplant (HT), as it is in some centers, is controversial. In our centre, patients older than 65 years ... -
Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry
(Wiley, 2017-10-08)[Abstract] Aims. The aim of this study was to assess long‐term safety of intravenous cardiovascular agents—vasodilators, inotropes and/or vasopressors—in acute heart failure (AHF). Methods and results. The European Society ... -
Lung cancer after heart transplantation: results from a large multicenter registry
(Wiley, 2011-04-26)[Abstract] In this study we analyzed Spanish Post-Heart-Transplant Tumour Registry data for adult heart transplantation (HT) patients since 1984. Median post-HT follow-up of 4357 patients was 6.7 years. Lung cancer (mainly ... -
Malignancy after heart transplantation: incidence, prognosis and risk factors
(Wiley, 2008-04-14)[Abstract] The Spanish Post-Heart-Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003). This retrospective analysis of 3393 patients investigated ... -
Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study
(Wiley Online Library, 2021-03-12)[Abstract] Male patients are at increased risk for developing malignancy postheart transplantation (HT); however, real incidence and prognosis in both genders remain unknown. The aim of this study was to assess differences ... -
Mechanical circulatory support in severe primary graft dysfunction: peripheral cannulation but not earlier implantation improves survival in heart transplantation
(Elsevier, 2023-03-15)[Abstract] Background. Primary graft dysfunction (PGD) still affects 2-28% of heart transplants (HT). Severe PGD requires mechanical circulatory support (MCS) and is the main cause of death early after HT. Earlier initiation ... -
Minimal traumatic aortic injuries: meaning and natural history
(Oxford University Press, 2012-03-21)[Abstract] Objective. Minimal aortic injuries (MAIs) are being recognized more frequently due to the increasing use of high-resolution diagnostic techniques. The objective of this case series review was to report the ... -
Moral experiences in caring for voluntary pregnancy losses: a meta-ethnography
(SAGE, 2022-05-12)[Abstract] Voluntary abortions are relatively frequent and their care is complex due to the social stigma that surrounds these losses. This interpretive meta-ethnography of 11 original qualitative articles aims to synthesize ... -
Mortality after the first hospital admission for acute heart failure, de novo versus acutely decompensated heart failure with reduced ejection fraction
(Elsevier, 2023-04-21)[Abstract] It is not clear to date whether a first admission in heart failure (HF) marks a worse evolution in patients not previously diagnosed with HF ("de novo HF") than those already diagnosed as outpatients ("acutely ... -
Multicultural coping experiences of parents following perinatal loss: a meta-ethnographic synthesis
(Wiley, 2019-09-30)[Abstract] Aims: To synthesize research findings regarding the coping experiences of parents following perinatal loss. Design: Noblit and Hare's interpretive meta-ethnography was followed. Data sources: A comprehensive ... -
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
(Springer, 2016)[Abstract] There are multiple intrinsic mechanisms for diastolic dysfunction ranging from molecular to structural derangements in ventricular myocardium. The molecular mechanisms regulating the progression from normal ... -
New data about atrial fibrillation, comment to the OFRECE study: response
(Elsevier, 2014-03-27) -
Novice Nurses’ Transition to the Clinical Setting in the COVID‐19 Pandemic: A Phenomenological Hermeneutic Study
(Elsevier, 2022-04-11)[Abstract] Background: : The COVID-19 pandemic both exposed and increased weaknesses in the healthcare system, so that novice nurses have become a more vulnerable group during this context. Aim: : This study sought to ... -
Nuevos modelos de currículum vitae en la era digital
(Scielo, 2018)[Resumen] El Currículum vitae es la carta de presentación en el ámbito profesional. Permite que las instituciones valoren nuestras competencias educativas y profesionales desarrolladas. La llegada de Internet, y más ... -
Obesity and asthma: an association modified by age
(Elsevier, 2013)[Abstract] Background. Some studies indicate some causal relationship between obesity and asthma, while others show inconsistent results. Our objective was to evaluate the prevalence of asthma according to obesity in ... -
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: GALACTIC‐HF Baseline Characteristics and Comparison With Contemporary Clinical Trials
(Willey Online Library, 2020-09-20)[Abstract] Aims The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is being tested in the Global Approach ...